Literature DB >> 5004005

Metabolism of the schistosomicidal agent hycanthone by rats and rhesus monkeys.

P Hernandez, E W Dennis, A Farah.   

Abstract

The absorption, distribution, and excretion of hycanthone were studied with rats and rhesus monkeys using tritiated materials at the therapeutic dose recommended for man (3.0+/-0.5 mg/kg). Nine pairs of each species received single intramuscular doses of randomly tritiated (specific activity 193.7 mCi/mmol) hycanthone methanesulfonate and were then sacrificed at intervals between 15 min and 72 h after medication. Peak blood and tissue concentrations occurred 30-60 min after administration (plasma half-life-45 min). The highest concentrations were observed in the liver, spleen, kidneys and adrenals, but decreased rapidly (more than 80% of the dose was excreted in 48-72 hours). In monkeys a high concentration of the compound was found in the bile (hours 1-8), probably conjugated to glucuronic acid.Radiochromatography showed only unchanged drug in the blood and tissues, except in the liver where rapid conversion occurred to sulfoxide in the rat and to the deethyl analogue in the monkey.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5004005      PMCID: PMC2427886     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  Determination of liquid scientillation counting efficiency by pulse height shift.

Authors:  L A BAILLIE
Journal:  Int J Appl Radiat Isot       Date:  1960-05

2.  Oogram studies with Hycanthone, a new antischistosomal agent.

Authors:  J Pellegrino; N Katz; J F Scherrer
Journal:  J Parasitol       Date:  1967-02       Impact factor: 1.276

3.  A new active metabolite of "Miracil D".

Authors:  D Rosi; G Peruzzotti; E W Dennis; D A Berberian; H Freele; S Archer
Journal:  Nature       Date:  1965-12-04       Impact factor: 49.962

4.  Further clinical trials with hycanthone, a new antischistosomal agent.

Authors:  N Katz; J Pellegrino; C A Oliveira
Journal:  Am J Trop Med Hyg       Date:  1969-11       Impact factor: 2.345

5.  Preliminary clinical trials with hycanthone, a new antischistosomal agent.

Authors:  N Katz; J Pellegrino; M T Ferreira; C A Oliveira; C B Dias
Journal:  Am J Trop Med Hyg       Date:  1968-09       Impact factor: 2.345

6.  Hycanthone therapy in bilharziasis.

Authors:  J C Maritz
Journal:  S Afr Med J       Date:  1970-01-31

7.  Field trial of hycanthone (Etrenol Winthrop) in the treatment of urinary and intestinal bilharziasis.

Authors:  V de V Clarke; D M Blair; M C Weber
Journal:  Cent Afr J Med       Date:  1969-01

8.  A comparison of oral and parenteral activity of hycanthone and lucanthone in experimental infections with Schistosoma mansoni.

Authors:  D A Berberian; H Freele; D Rosi; E W Dennis; S Archer
Journal:  Am J Trop Med Hyg       Date:  1967-07       Impact factor: 2.345

9.  Schistosomicidal activity of lucanthone hydrochloride, hycanthone and their metabolites in mice and hamsters.

Authors:  D A Berberian; H Freele; D Rosi; E W Dennis; S Archer
Journal:  J Parasitol       Date:  1967-04       Impact factor: 1.276

10.  The uptake of tritiated hycanthone by male and female Schistosoma mansoni worms and distribution of the drug in plasma and whole blood of mice following a single intramuscular injection.

Authors:  A Yarinsky; P Hernandez; E W Dennis
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  2 in total

Review 1.  Schistosomiasis drug therapy and treatment considerations.

Authors:  K C Shekhar
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.